Industry Segments and Geographic Information

9 Months Ended

May 31, 2014

Segment Reporting [Abstract]

Segment Reporting Disclosure [Text Block]

Industry Segments and Geographic Information

The Industry Segment “U.S. Division” comprises of the Company’s Pasadena facility. The Company at the present time has the U.S. Division and the Corporate Division.

Certain previously reported financial information has been reclassified to conform to the current period’s presentation.

Corporate Division

The Company closed the Garland facility on September 30, 2011, and sold it in July 2013. The Company took an impairment charge of approximately $1.1 million during the three months ended August 31, 2012, based on the sales price negotiated at that time. An additional loss of $122,975 was taken based on the final sales price during the three months ended August 31, 2013.

The Company organized Sino Bond to hold and manage investments in Hong Kong. Sino Bond invests in debt instruments (corporate and municipal) and equity securities in Europe and Asia, including initial public offerings and pre-initial public offerings. The Company invests in various marketable securities. During the three months ended November 30, 2012, one particular security was called on which the Company had a gain of approximately $2.2 million. As of May 31, 2014, the balance of these securities is valued at approximately $21.3 million. During the nine months ended May 31, 2014 and 2013, the Company also traded in initial public offerings of equity securities on the Hong Kong Stock Exchange and had a net gain of $161,864 and $706,350, respectively. During the first quarter of fiscal year 2014, the Company sold all of its trading securities and does not hold any such securities as of May 31, 2014.

The Corporate Division includes interest and other income related to its investments in securities, corporate personnel compensation expenses, and general and administrative expenses. Such expenses and income are not allocated to our operating division, as they relate to our general corporate activities.

We generally evaluate performance based on profit or loss from operations before income taxes and non-recurring charges and other criteria. The accounting policies of the reportable segments are the same as those described in the summary of significant accounting policies. There are no transfers between segments.

Summarized financial information concerning the business segments from continuing operations is as follows:

	Three months ended May 31,				Nine months ended May 31,
	2014		2013		2014		2013
Revenues from external customers
Net patient service revenues
U.S. Division	$	2,748,772	$	1,558,762	$	7,239,406	$	4,514,611
Corporate		—		—		—		—
Consolidated	$	2,748,772	$	1,558,762	$	7,239,406	$	4,514,611
Income (loss) before taxes and discontinued operations
U.S. Division	$	186,954	$	(906,152)	$	(165,472)	$	(2,388,929)
Corporate		(486,423)		(523,898)		(1,360,423)		146,312
Consolidated	$	(299,469)	$	(1,430,050)	$	(1,525,895)	$	(2,242,617)

	May 31, 2014		August 31, 2013
Total Assets
U.S. Division	$	15,303,810	$	9,924,501
Corporate		32,792,701		31,711,826
Consolidated	$	48,096,511	$	41,636,327